Citius Oncology Inc (NASDAQ:CTOR) currently has a daily average trading volume of 1.90M but it saw 8363850 shares traded in last market. With a market cap of 197.48M USD, the company’s current market price of $2.76 came rising about 3.76 while comparing to the previous closing price of $2.66. In past 52 weeks, the stock remained buoying in the range of price level as high as $49.00 and as low as $0.55. In the recent trading on the day, stock has struck highest price mark of $2.43 while lowest mark touched by it was $2.99.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Maxim Group which initiated the stock as “Buy” in its note to investors issued on November 27, 2024, recommending a price target of $3 for it.
Over the week, CTOR’s stock price is moving 90.34% up while it is 203.30% when we observe its performance for the past one month. Year-to-date it is -75.51% down and over the past year, the stock is showing an upside performance of 140.00%.
The company is expected to be releasing its next quarterly report on 2025-May-14, for which analysts forecasted an EPS of 0 while estimate for next year EPS is 0.
Currently, Citius Oncology Inc’s total number of outstanding shares is 71.55M with 95.07% of that held by the insiders while 0.76% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -52.88%. It has a 55.20 of forward P/E ratio. Stock’s beta reads 0.66. Stock has a price to book (P/B) ratio of 5.54.
